health
May 3, 2026
Pharmaceutical company asks to restore access to abortion pill by mail, to avoid 'chaos'
Pharmaceutical company asks to restore access to abortion pill by mail, to avoid 'chaos' Photo: iStock
TL;DR
- Danco, the first company approved to produce the abortion pill mifepristone, is seeking temporary restoration of access from the Supreme Court.
- The company warns that the suspension of sales will lead to 'immediate chaos' and uncertainty.
- A federal appeals court had temporarily reinstated a rule requiring in-person dispensing of abortion pills, prohibiting mail delivery.
- Mifepristone was used in 63% of abortions in the U.S. in 2023.
- The legal battle centers on regulations allowing telemedicine prescriptions and mail-order dispensing, which critics argue circumvent state abortion bans.
- The ACLU stated that restricting access through telemedicine endangers women in rural areas, those experiencing domestic violence, or those with disabilities.